T. Welte (Hanover, Germany), S. Hartl (Vienna, Austria)
The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease
Y. Lin, T. Yang, C. Wang (Beijing, China)
|    |
SGRQ-C distribution in the evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) cohort: Characteristics of COPD subjects with extreme score quintiles
H. Müllerova, N. Locantore, R. Tal-Singer, P. Jones (Uxbridge, United Kingdom; RTP, King of Prussia, United States Of America)
| |
Impact of symptomatology in patients with GOLD stage I COPD
P. Gagnon, D. Saey, S. Provencher, J. Milot, F. Maltais (Canada)
| |
Effect of polymeric lung volume reduction (PLVR) therapy on composite COPD outcome measures
A. Valipour, F. Herth, R. Eberhardt, F. Stanzel, R. Bonnet, J. Behr, B. Schmidt, H. Magnussen (Vienna, Austria; Halle, , Bad Berka, Berlin, Germany)
| |
Novel patterns of serum biomarkers profiling using minimal important clinical outcomes (MICO) in the longidutinal study BODE cohort of COPD patients
C. Casanova, V. Pinto-Plata, J. P. de Torres, H. Mullerova, H. Corado, N. Varo, R. Baz, E. Cordoba, S. Zeineldine, B. Celli (Tenerife, Pamplona, Spain; Boston, United States Of America; London, United Kingdom)
| |
CT phenotype correlates with health status and BODE in COPD
M. Han, G. Washko, M. Dransfield, L. Liu, N. Marchetti, R. Casaburi, E. Regan, N. Hanania, D. Lynch, J. Schroeder, F. Martinez (Ann Arbor, Boston, Birmingham, Philadelphia, Los Angeles, Denver, Houston, United States Of America)
| |
Validity and precision of the Leicester Cough Questionnaire in COPD patients with chronic cough
N. ten Hertog, S. Uil, L. Boom, J. W. van den Berg (Zwolle, Netherlands)
| |
The VQ11, concomitant validity and reproducibility of a specific health related quality of life short questionnaire in patients with stable COPD for routine care
N. Gregory, S. Fares, P. Christian (Montpellier, France)
| |